Supreme Court of Canada rejects “unsound” promise doctrine
In the eagerly-awaited AstraZeneca Canada v Apotex ruling, Canada’s Supreme Court has struck down the “promise doctrine” and clarified the requirement for patent utility
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
